252 related articles for article (PubMed ID: 25179220)
1. Computational and biochemical docking of the irreversible cocaine analog RTI 82 directly demonstrates ligand positioning in the dopamine transporter central substrate-binding site.
Dahal RA; Pramod AB; Sharma B; Krout D; Foster JD; Cha JH; Cao J; Newman AH; Lever JR; Vaughan RA; Henry LK
J Biol Chem; 2014 Oct; 289(43):29712-27. PubMed ID: 25179220
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor mechanisms in the S1 binding site of the dopamine transporter defined by multi-site molecular tethering of photoactive cocaine analogs.
Krout D; Pramod AB; Dahal RA; Tomlinson MJ; Sharma B; Foster JD; Zou MF; Boatang C; Newman AH; Lever JR; Vaughan RA; Henry LK
Biochem Pharmacol; 2017 Oct; 142():204-215. PubMed ID: 28734777
[TBL] [Abstract][Full Text] [Related]
3. Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I]iodophenyl)butyl]-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane implicates proximity of cocaine and substrate active sites.
Parnas ML; Gaffaney JD; Zou MF; Lever JR; Newman AH; Vaughan RA
Mol Pharmacol; 2008 Apr; 73(4):1141-50. PubMed ID: 18216182
[TBL] [Abstract][Full Text] [Related]
4. Localization of cocaine analog [125I]RTI 82 irreversible binding to transmembrane domain 6 of the dopamine transporter.
Vaughan RA; Sakrikar DS; Parnas ML; Adkins S; Foster JD; Duval RA; Lever JR; Kulkarni SS; Hauck-Newman A
J Biol Chem; 2007 Mar; 282(12):8915-25. PubMed ID: 17255098
[TBL] [Abstract][Full Text] [Related]
5. Differential binding of tropane-based photoaffinity ligands on the dopamine transporter.
Vaughan RA; Agoston GE; Lever JR; Newman AH
J Neurosci; 1999 Jan; 19(2):630-6. PubMed ID: 9880583
[TBL] [Abstract][Full Text] [Related]
6. Identification of the benztropine analog [
Tomlinson MJ; Krout D; Pramod AB; Lever JR; Newman AH; Henry LK; Vaughan RA
Neurochem Int; 2019 Feb; 123():34-45. PubMed ID: 30125594
[TBL] [Abstract][Full Text] [Related]
7. Interaction of tyrosine 151 in norepinephrine transporter with the 2β group of cocaine analog RTI-113.
Hill ER; Huang X; Zhan CG; Ivy Carroll F; Gu HH
Neuropharmacology; 2011; 61(1-2):112-20. PubMed ID: 21420984
[TBL] [Abstract][Full Text] [Related]
8. Novel tropane-based irreversible ligands for the dopamine transporter.
Zou MF; Kopajtic T; Katz JL; Wirtz S; Justice JB; Newman AH
J Med Chem; 2001 Dec; 44(25):4453-61. PubMed ID: 11728190
[TBL] [Abstract][Full Text] [Related]
9. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
[TBL] [Abstract][Full Text] [Related]
10. Functional properties of dopamine transporter oligomers after copper linking.
Zhen J; Reith MEA
J Neurochem; 2018 Jan; 144(2):162-171. PubMed ID: 29168892
[TBL] [Abstract][Full Text] [Related]
11. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis.
Chen N; Vaughan RA; Reith ME
J Neurochem; 2001 May; 77(4):1116-27. PubMed ID: 11359877
[TBL] [Abstract][Full Text] [Related]
12. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporter ligand binding domains. Structural and functional properties revealed by limited proteolysis.
Vaughan RA; Kuhar MJ
J Biol Chem; 1996 Aug; 271(35):21672-80. PubMed ID: 8702957
[TBL] [Abstract][Full Text] [Related]
14. 2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter.
Hiranita T; Wilkinson DS; Hong WC; Zou MF; Kopajtic TA; Soto PL; Lupica CR; Newman AH; Katz JL
J Pharmacol Exp Ther; 2014 May; 349(2):297-309. PubMed ID: 24518035
[TBL] [Abstract][Full Text] [Related]
15. Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping.
Vaughan RA
Mol Pharmacol; 1995 May; 47(5):956-64. PubMed ID: 7746282
[TBL] [Abstract][Full Text] [Related]
16. Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.
Wilcox KM; Lindsey KP; Votaw JR; Goodman MM; Martarello L; Carroll FI; Howell LL
Synapse; 2002 Jan; 43(1):78-85. PubMed ID: 11746736
[TBL] [Abstract][Full Text] [Related]
17. Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes.
Silverthorn ML; Dersch CM; Baumann MH; Cadet JL; Partilla JS; Rice KC; Carroll FI; Becketts KM; Brockington A; Rothman RB
J Pharmacol Exp Ther; 1995 Apr; 273(1):213-22. PubMed ID: 7714769
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and transporter binding properties of 3beta-[4'-(phenylalkyl, -phenylalkenyl, and -phenylalkynyl)phenyl]tropane-2beta-carboxylic acid methyl esters: evidence of a remote phenyl binding domain on the dopamine transporter.
Blough BE; Keverline KI; Nie Z; Navarro H; Kuhar MJ; Carroll FI
J Med Chem; 2002 Aug; 45(18):4029-37. PubMed ID: 12190324
[TBL] [Abstract][Full Text] [Related]
19. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.
Minuzzi L; Olsen AK; Bender D; Arnfred S; Grant R; Danielsen EH; Cumming P
Synapse; 2006 Mar; 59(4):211-9. PubMed ID: 16385509
[TBL] [Abstract][Full Text] [Related]
20. Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs.
Eriksen J; Rasmussen SG; Rasmussen TN; Vaegter CB; Cha JH; Zou MF; Newman AH; Gether U
J Neurosci; 2009 May; 29(21):6794-808. PubMed ID: 19474307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
